Remove Government Remove Pharmaceutical manufacturing Remove Specialization
article thumbnail

Novel two-chamber setup could predict HPAPI dustiness

European Pharmaceutical Review

Processes in pharmaceutical manufacturing such as processing, milling, grinding, and mixing, are associated with the generation of dust. To guarantee the safe manufacture of dosage forms containing HPAPIs, special production setups are applied which are operated at a negative pressure.

article thumbnail

Cleanrooms-on-demand: a more efficient future for pharma?

pharmaphorum

However, with cleanrooms-on-demand representing a feasible and accessible opportunity for those across pharmaceutical manufacturing, what are the key challenges in adoption and how can we expect the industry to overcome them to reap the rewards on offer? But with a single dedicated cleanroom environment costing around $2.5

Pharma 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Supply Chain Planning Can Help Pharma Meet All-Time High Drug Supply Demands

PM360

The end-to-end supply chain comprises material procurement, manufacturing, transportation, warehousing, and distribution. For pharmaceutical manufacturing, many of these processes are subject to good manufacturing practice (GxP) and oversight by regulatory bodies. Some suggest that the government should incentivize U.S.

article thumbnail

The Pandemic Treaty and the opportunity to end ‘vaccine apartheid’

pharmaphorum

The UN Special Rapporteur on contemporary forms of racism, E. Compounding the situation to understand how such an outcome was allowed to occur is the fact that many deals between government and pharmaceutical companies selling the treatments and vaccines were agreed under terms of confidentiality.

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

Founded in 1935 by Chiesi’s grandfather of the same name, Chiesi Group focuses on respiratory conditions, special care, and on rare diseases, including lysosomal storage disorders and rare haematological and ophthalmological diseases. “An

article thumbnail

Precision Medicine Needs an Overhaul

PM360

When once a small population needed a special status called “rare”, now all diseases will be defined by endotypes and phenotypes – smaller segments of like patients with common molecular characteristics. The UK government also founded and expanded the UK Biobank, establishing Genomics England , to run the 100,000 Genomes Project.